METTL14 and neoplasm: However, METTL14 has been identified to be decreased in bladder cancer and related tumor initiating cells (TICs), knockdown of which promotes the cell proliferation, self-renewal, metastasis and tumor initiating capacity through reducing the stability of m6A-modified Notch1 mRNA202.